Theravance Biopharma furnishes investor slide deck for H.C. Wainwright conference

Theravance Biopharma, Inc.

Management team participating in fireside chat at H.C. Wainwright 25th Annual Global Investment Conference on Sep 12, 2023.
Slide presentation furnished as Exhibit 99.1 under Regulation FD; no specific financial or operational updates disclosed in the filing.
The filing does not contain earnings figures, guidance changes, or corporate developments beyond the conference schedule.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.